Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN – Get Free Report) shares passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.13 and traded as high as $0.20. Enzon Pharmaceuticals shares last traded at $0.19, with a volume of 683,174 shares traded.
Enzon Pharmaceuticals Stock Up 44.9 %
The company has a market cap of $13.95 million, a PE ratio of 18.81 and a beta of 0.49. The firm has a 50 day simple moving average of $0.10 and a 200-day simple moving average of $0.13.
Enzon Pharmaceuticals Company Profile
Enzon Pharmaceuticals, Inc, together with its subsidiaries, does not have significant operations. Previously, the company marketed its patented drug product, PegIntron. It also had a marketing agreement with Micromet AG relating to the Vicineum drug; and a licensing agreement regarding SC Oncaspar and certain other drugs.
Recommended Stories
- Five stocks we like better than Enzon Pharmaceuticals
- 3 Tickers Leading a Meme Stock Revival
- XPO Stock Gains Momentum as U.S. Trade Outlook Evolves
- How to Use the MarketBeat Stock Screener
- CarMax Gets in Gear: Is Now the Time to Buy?
- EV Stocks and How to Profit from Them
- Qubit Combat: 2 Stocks Battle for Quantum Supremacy
Receive News & Ratings for Enzon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enzon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
